[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

Nicotine and Fish

Genocide Summer Camp, And Other Notes From The Edge Of The Narrative Matrix

This Can Create Endless Green Energy WITHOUT Electricity

Geoengineering: Who’s Behind It and How We Stop It

Pam Bondi Ordered Prosecution of Dr. Kirk Moore After Refusing to Dismiss Case

California woman bombarded with Amazon packages for over a year

CVS ordered to pay $949 MILLION in Medicaid fraud case.

Starmer has signed up to the UNs agreement to raise taxes in the UK

Magic mushrooms may hold the secret to longevity: Psilocybin extends lifespan by 57% in groundbreaking study

Cops favorite AI tool automatically deletes evidence of when AI was used

Leftist Anti ICE Extremist OPENS FIRE On Cops, $50,000 REWARD For Shooter

With great power comes no accountability.

Auto loan debt hits $1.63T. 20% of buyers now pay $1,000+ monthly. Texas delinquency hits 7.92%.

Quotable Quotes from the Chosenites

Tokara Islands NOW crashing into the Ocean ! Mysterious Swarm continues with OVER 1700 Quakes !

Why Austria Is Suddenly Declaring War on Immigration

Rep. Greene Wants To Remove $500 Million in Military Aid for Nuclear-Armed Israel From NDAA

Netanyahu Lays Groundwork for Additional Strikes on Iran: 'We Didn't Deal With The Enriched Uranium'

Sweden Cracks Down On OnlyFans - Will U.S. Follow Suit?

Joe Rogan CALLS OUT Israel's Media CONTROL

Communist Billionaire Accused Of Funding Anti-ICE Riots Mysteriously Vanishes

6 Factors That Describe China's Current State

Trump Thteatens to Bomb Moscow and Beijing

Little Bitty

Vertiv Drops After Amazon Unveils In-House Liquid Cooling System, Marking Pivot To Liquid

17 Out-Of-Place Artifacts That Suggest High-Tech Civilizations Existed Thousands (Or Millions) Of Years Ago

Hamas Still Killing IDF Soldiers After 642 Days

Copper underpins every part of the economy. If you want to destroy the U.S. economy this is how you would do it.

Egyptian Pres. Gamal Abdel Nassers Chilling Decades-Old Prediction About Israel-Palstine Conflict.

Debt jumps $366B in one day.


Science/Tech
See other Science/Tech Articles

Title: Genes May Play a Role in Response to Preemie Prevention Treatment
Source: MedPageToday
URL Source: http://www.medpagetoday.com/MeetingCoverage/SMFM/12729
Published: Feb 3, 2009
Author: Todd Neale
Post Date: 2009-02-06 15:33:10 by Prefrontal Vortex
Keywords: None
Views: 7

SMFM: Society for Maternal-Fetal Medicine Meeting

SMFM: Genes May Play a Role in Response to Preemie Prevention Treatment

By Todd Neale, Staff Writer, MedPage Today
Published: February 03, 2009
Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine.

SAN DIEGO, Feb. 3 -- Genetic variation in the human progesterone receptor may explain why treatment to prevent recurrent preterm birth does not work in some women, researchers found.

Certain single nucleotide polymorphisms seemed to play a role in the efficacy of 17 alpha-hydroxyprogesterone caproate, said Tracy Manuck, M.D., of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network in Bethesda, Md.

She described the results as exploratory, but told attendees at the Society for Maternal-Fetal Medicine meeting that "further studies may lead to the creation of a response panel, enabling clinicians to direct therapy to those women most likely to benefit."

"This research provides important preliminary information and direction for future investigation of progesterone receptor gene variation and the etiology and treatment of preterm birth," she said.

Dr. Manuck and colleagues conducted a secondary analysis of women who were enrolled in a prospective, multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy of 17 alpha-hydroxyprogesterone caproate for preventing a second preterm birth in women who had previously had one.

That study found that the drug reduced the rate of recurrent preterm birth by about 33%, but Dr. Manuck and her colleagues wanted to find out whether genetic variation in the targeted receptor modulated its benefits.

So they extracted DNA from stored saliva samples for 258 women who had received active treatment and 131 who had received placebo.

Most of the women (59.6%) were black, 39.6% gave birth before 37 weeks gestation, and 12.1% gave birth before 32 weeks gestation.

More than a quarter (28%) had had more than one previous spontaneous preterm birth.

The researchers examined 20 SNPs on the progesterone receptor, a handful of which were significantly correlated with response to treatment.

Among black women who were homozygous for the major allele on SNP rs471767, those who received active treatment had a significantly reduced rate of preterm birth compared with those who received placebo (21% versus 60%, P=0.0229).

Those who had at least one copy of the minor allele, however, did not derive any benefit from active treatment.

Looking at another SNP -- rs578029 -- the researchers found that among black women who had a least one copy of the major allele, those who received active treatment had a significant reduction in preterm birth (25% versus 55%, P=0.0289).

Those who had two copies of the minor allele did not benefit from treatment.

Similar relationships were found among non-black women who gave birth at less than 32 weeks gestation.

Those who had a least one copy of the minor allele on yet another SNP -- rs503362 -- had a significant reduction with active treatment (2.6% versus 17.4%, P=0.0263).

Similarly, non-black women who had at least one copy of the minor allele on a fourth SNP -- rs666553 -- had a significant reduction in very preterm birth compared with placebo (3.4% versus 26.7%, P=0.0382).

Among non-black women who were homozygous for the major allele on both of those SNPs, rates of very preterm birth were similar in those who received active treatment and those who received placebo.

Dr. Manuck said the findings indicated that "the clinical efficacy of 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth may be altered by polymorphisms in the progesterone receptor gene."

Post Comment   Private Reply   Ignore Thread  



[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]